David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 5,000 shares at $24.34 ($122K) on 2025-09-16, disclosed to the SEC on 2025-09-18.
Scheduled sale ($122k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |